Voici le compte rendu hebdomadaire du forum de la Harvard Law School sur la gouvernance corporative au 7 mai 2020.
Cette semaine, j’ai relevé les dix principaux billets.
Bonne lecture !
- Key Considerations for U.S. Public Company Compensation Committees in Light of COVID-19
- A New Era For Activist Defense: Going Beyond the Relics of the 80s
- COVID-19 and Capital Allocation
- The Pandemic is the Litmus Test of Stakeholderism
- Corporate Immunity to the COVID-19 Pandemic
- Considerations on Non-Employee Director Compensation
- The Return of Poison Pills: A First Look at “Crisis Pills”
- Board Members Preparedness for Major Risk Event Like COVID-19
- Asian Americans in the Boardroom
- Reconsidering Activism in France
